Jones Financial Companies’s Lucid Diagnostics LUCD Stock Holding History

Jones Financial Companies’s Portfolio LUCD Stock Details LUCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09K	Hold	1,010	–	–	﹤0.01%	4588
2026 Q1	$1.13K	Hold	1,010	–	–	﹤0.01%	4319
2025 Q4	$1.1K	Sell	1,010 -100	-9%	-$112	﹤0.01%	3991
2025 Q3	$1.14K	Buy	1,110 +100	+10%	+$109	﹤0.01%	3859
2025 Q2	$1.18K	Hold	1,010	–	–	﹤0.01%	3617
2025 Q1	$1.6K	Buy	1,010 +1,000	+10,000%	+$1.2K	﹤0.01%	3299
2024 Q4	$8	Sell	10 -1,906	-99%	-$1.68K	﹤0.01%	3406
2024 Q3	$1.5K	Sell	1,916 -1,915	-50%	-$1.57K	﹤0.01%	2735
2024 Q2	$3.14K	Hold	3,831	–	–	﹤0.01%	2062
2024 Q1	$3.1K	Buy	+3,831	New	+$4.97K	﹤0.01%	1227

Other funds holding LUCD

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Jones Financial Companies's LUCD Position: Q2 2026 in Review

Jones Financial Companies held its Lucid Diagnostics (LUCD) position steady in Q2 2026 at 1,010 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #4588.

Jones Financial Companies first reported a position in LUCD in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.14K in Q2 2024. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

Jones Financial Companies held 1,010 shares of Lucid Diagnostics worth $1.09K as of Q2 2026.
Jones Financial Companies left its Lucid Diagnostics share count unchanged in Q2 2026.
Lucid Diagnostics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4588 holding.
Jones Financial Companies first reported a position in Lucid Diagnostics in Q1 2024 and has held it in 10 quarters since.
Jones Financial Companies's Lucid Diagnostics position peaked at $3.14K in Q2 2024.
116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.